Season 1, Episode 1
Smart KPIs for Biotechs
Sabine Hutchison and Alan Morgan discuss the importance of measuring what truly matters in clinical trials and the significance of smart Key Performance Indicators (KPIs) for Biotech companies.
Listen to the full episode right now!
Seuss+ CEO and Co-Founder Sabine Hutchison is joined by Alan Morgan. Alan has worked as a leader in the industry for 25 years and sits down with Sabine to discuss the importance of measuring what truly matters in clinical trials and the significance of smart Key Performance Indicators (KPIs) for Biotech companies.
Alan Morgan is an experienced leader in pharmaceutical services, having operated in C suite roles for 25 years. He is an advisor and consultant within Private Equity, a non-executive advisor to Excelya in Paris, non-executive chairman of Gentronix Limited (a genetic toxicology early stage CRO PE backed), and an advisor to Luure.ai , a US based AI tech startup.
Join the discussion and listen to the full episode here.
Related Episodes
Episode 3 – Cracking the code: Navigating the Ever-Changing Biotech Landscape
Season 1, Episode 3 Cracking the code: Navigating the Ever-Changing Biotech LandscapeSabine Hutchison sits down with the accomplished Dr. Allison Jeynes-Ellis, a visionary leader whose journey spans medicine, oncology, and the life sciences. Join Seuss+ CEO and...
Episode 2 Innovation Unleashed: Exploring the Intersection of Science and Creativity – An Unconventional Growth Strategy
Season 1, Episode 2 Innovation Unleashed: Exploring the Intersection of Science and Creativity - An Unconventional Growth StrategySabine and Jennifer explore the captivating world where biotech science and creativity unite. Discover their secrets to success and get...
Stay Connected to Get The Latest Podcast Alerts
CUT THE CHAT - LIFE SCIENCE INSIDER
Listen Now!
An informative podcast series designed quite literally cut the unnecessary talk and get straight to the point and heart of many life science and Biotech conversations that need to happen for our industry to evolve, innovate and get smarter—faster.
0 Comments